TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT05272059

Multiple Ascending Dose Study of MHS552 in Adults With Type 1 Diabetes Mellitus

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.
“Sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

202220232024Registered2022-02-28Withdrawn (as of)2023-04-07Planned start2023-09-01 (planned)

Vital statistics

Status
Withdrawn
Phase
Phase 1
Sponsor
Novartis Pharmaceuticals
Sponsor type
Industry
Conditions
Type 1 Diabetes Mellitus
Interventions
MHS552; Placebo
Participants
0

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.